Amneal announces strategic european partnership with orion corporation

Bridgewater, n.j.--( business wire )--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) today announced it has signed a long-term license agreement with orion corporation (omxh: ornbv & ornav) to commercialize a number of amneal's complex generic products.

AMRX Ratings Summary

AMRX Quant Ranking